Bausch Health Companies Inc
DUS:BVF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bausch Health Companies Inc
DUS:BVF
|
CA |
|
V
|
Veeco Instruments Inc
XMUN:VEO
|
US |
|
S
|
Sinotruk Hong Kong Ltd
F:4SK
|
CN |
|
Argosy Minerals Ltd
F:AM1
|
AU |
|
Schrodinger Inc
NASDAQ:SDGR
|
US |
|
Duerr AG
F:DUE
|
DE |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
Straumann Holding AG
F:QS5
|
CH |
|
Pharming Group NV
F:PHG
|
NL |
Wall St Price Targets
BVF Price Targets Summary
Bausch Health Companies Inc
According to Wall Street analysts, the average 1-year price target for BVF is 5.464 EUR with a low forecast of 5.41 EUR and a high forecast of 5.625 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BVF's stock price target?
Price Target
5.464
EUR
According to Wall Street analysts, the average 1-year price target for BVF is 5.464 EUR with a low forecast of 5.41 EUR and a high forecast of 5.625 EUR.
What is the Revenue forecast for Bausch Health Companies Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 0%.
What is the Gross Profit forecast for Bausch Health Companies Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 7 years is -2%.
What is the Operating Income forecast for Bausch Health Companies Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 7 years is 5%.
What is the Pre-Tax Income forecast for Bausch Health Companies Inc?
Projected CAGR
61%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 61%.
What is the Net Income forecast for Bausch Health Companies Inc?
Projected CAGR
38%
The compound annual growth rate for Net Income over the next 7 years is 38%.
